artificial oligonucleotide-mimics
molecular medicine
novel oligonucleotide-based materials
Hybrid Nanostructured Oligonucleotide Platforms
molecular biology
molecular target
bio-molecular interaction
collaborative scientific team
safe systemic delivery of oligonucleotide
test hybrid nanomaterials
international mobility
Nano-OligoMed
scientific aim of Nano
therapeutic function
artificial mimics
joint multidisciplinary scientific collaborative programme
Biomedical Applications Nanotechnology
collaborative transfer of knowledge
field of materials sciences
network of international collaboration
international academic networking
specific competences
creation of degradable hybrid structures
training activities
educational activities
specific input
therapeutic agents
intrinsic bio-responsive feature of oligonucleotides
delicate programmable oligonucleotides
extra-European countries
senior scientists
rigid
set-up
exchange
inert silica
broadening
widespread attention
combination
strategies
DNA
result
cancer drugs
PhD students
research skills
decades
sectors
presence
chemical payload
leading experts
miRNAs
activation
cell internalization
drug carrier
diversity of approaches
technological breakthroughs
degradation
ambition
great challenges
possibility
end
electronics
biomedicine